Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105

Affiliations

• ¹ Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan.
• ² Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
• ³ JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
• ⁴ Department of Hematology and Oncology, Hiroshima University Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.
• ⁵ Department of Hematology, Kyorin University Faculty of Medicine, Tokyo, Japan.
• ⁶ Department of Clinical Oncology and Hematology, The Jikei University Daisan Hospital, Tokyo, Japan.
• ⁷ Department of Hematology Oncology, Tokai University School of Medicine, Kanagawa, Japan.
• ⁸ Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
• ⁹ Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
• ¹⁰ Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
• ¹¹ Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
• ¹² Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama, Japan.
• ¹³ Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
• ¹⁴ Department of Hematology, Saitama Cancer Center, Saitama, Japan.
• ¹⁵ Department of Hematology, University of Occupational and Environmental Health, Kitakyusyu, Japan.
• ¹⁶ Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
• ¹⁷ Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
• ¹⁸ Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
• ¹⁹ Department of Hematology, Toyota Kosei Hospital, Toyota, Japan.
• ²⁰ Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
• ²¹ Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Hospital, Ehime, Japan.
• ²² Department of Hematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ²³ Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.